Insider Transactions in Q4 2024 at Generation Bio Co. (GBIO)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 15
2024
|
Yalonda Howze CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
983
-6.48%
|
-
|
|
Oct 15
2024
|
Yalonda Howze CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,347
+18.08%
|
$6,694
$2.42 P/Share
|
|
Oct 15
2024
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
468
-2.83%
|
$936
$2.42 P/Share
|
|
Oct 15
2024
|
Antoinette Paone CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,592
+8.79%
|
-
|
|
Oct 15
2024
|
Geoff Mcdonough PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,548
-0.12%
|
$3,096
$2.42 P/Share
|
|
Oct 15
2024
|
Geoff Mcdonough PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,274
+0.39%
|
-
|
|
Oct 15
2024
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
984
-0.86%
|
$1,968
$2.42 P/Share
|
|
Oct 15
2024
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,347
+2.84%
|
-
|
|
Oct 15
2024
|
Phillip Samayoa CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
337
-0.28%
|
$674
$2.42 P/Share
|
|
Oct 15
2024
|
Phillip Samayoa CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,147
+0.93%
|
-
|
|
Oct 15
2024
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
492
-0.2%
|
$984
$2.42 P/Share
|
|
Oct 15
2024
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,674
+0.67%
|
-
|